Portfolio (Quarterly)
Guide ↗
Candriam S.C.A.
· CIK 0001537014| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 677,629.0 | $53.6M | 0.27% | +66K | +10.9% | $79.11 | -6.3% |
| 42 | AWK | AMERICAN WTR WKS CO INC NEW | Utilities | 394,710.0 | $51.5M | 0.26% | +9K | +2.3% | $130.51 | -4.2% |
| 43 | KO | COCA COLA CO | Consumer Defensive | 711,745.0 | $49.8M | 0.25% | +48K | +7.3% | $69.91 | +13.6% |
| 44 | BMY | BRISTOL-MYERS SQUIBB CO | Healthcare | 906,714.0 | $48.9M | 0.24% | +9K | +1.1% | $53.94 | +0.1% |
| 45 | CELC | CELCUITY INC | Healthcare | 476,370.0 | $47.5M | 0.24% | +85K | +21.9% | $99.74 | -12.0% |
| 46 | HCA | HCA HEALTHCARE INC | Healthcare | 101,001.0 | $47.2M | 0.23% | +2K | +1.9% | $466.88 | -19.6% |
| 47 | COGT | COGENT BIOSCIENCES INC | Healthcare | 1,296,475.0 | $46.1M | 0.23% | +342K | +35.9% | $35.52 | -2.8% |
| 48 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 569,590.0 | $45.0M | 0.22% | +167K | +41.3% | $78.99 | +35.6% |
| 49 | XOM | EXXON MOBIL CORP | Energy | 345,821.0 | $41.6M | 0.21% | +27K | +8.5% | $120.35 | +16.9% |
| 50 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 293,096.0 | $41.6M | 0.21% | +5K | +1.9% | $141.84 | +11.6% |
| 51 | AEM | AGNICO EAGLE MINES LTD | Basic Materials | 244,626.0 | $41.5M | 0.21% | +26K | +12.1% | $169.71 | -1.8% |
| 52 | ZS | ZSCALER INC | Technology | 182,989.0 | $41.2M | 0.20% | +12K | +7.1% | $224.93 | -44.7% |
| 53 | ARGX | ARGENX SE | Healthcare | 48,741.0 | $41.0M | 0.20% | +541.0 | +1.1% | $840.99 | +4.4% |
| 54 | PLD | PROLOGIS INC. | Real Estate | 315,877.0 | $40.3M | 0.20% | +218K | +223.1% | $127.67 | +10.1% |
| 55 | DDOG | DATADOG INC | Technology | 295,017.0 | $40.1M | 0.20% | +23K | +8.4% | $136.00 | +64.0% |
| 56 | C | CITIGROUP INC | Financial Services | 343,030.0 | $40.0M | 0.20% | +111K | +47.8% | $116.69 | +22.6% |
| 57 | BLK | BLACKROCK INC | Financial Services | 37,369.0 | $40.0M | 0.20% | +7K | +23.0% | $1070.39 | -1.9% |
| 58 | — | ASCENDIS PHARMA A/S | — | 186,940.0 | $39.9M | 0.20% | +8K | +4.5% | $213.25 | — |
| 59 | TGT | TARGET CORP | Consumer Defensive | 404,549.0 | $39.5M | 0.20% | +147K | +56.9% | $97.75 | +33.7% |
| 60 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 830,961.0 | $38.7M | 0.19% | +86K | +11.5% | $46.55 | -22.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
34.2%
Healthcare
25.8%
Financial Services
11.2%
Consumer Cyclical
8.0%
Communication Services
7.2%
Industrials
5.5%
Consumer Defensive
2.6%
Utilities
1.7%
Basic Materials
1.5%
Real Estate
1.4%